跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vasoactive intestinal peptide
首页
药物
Vasoactive intestinal peptide
Investigational
Small Molecule
Vasoactive intestinal peptide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
147
H
237
N
43
O
43
S
CAS 编号
37221-79-7
UNII ID
6J2WVD66KR
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS
EP 3256151 B1
申请人: PHASEBIO PHARMACEUTICALS INC
优先权: 2015
CN
EP
US
WO
10 件公开
METHODS OF TREATING CANCER AND INFECTIOUS DISEASES USING CELL BASED THERAPIES
EP 3439685 A1
申请人: UNIV EMORY
优先权: 2016
CN
EP
US
WO
9 件公开
VIP fragments and methods of use
US 8470778 B2
申请人: DUGGAN KAREN ANNETTE
优先权: 2005
US
7 件公开
VASOACTIVE INTESTINAL PEPTIDE (VIP) RECEPTOR ANTAGONISTS
EP 4341282 A4
申请人: UNIV EMORY
优先权: 2021
CN
EP
US
WO
6 件公开
Microorganism expressing vasoactive intestinal peptide, and use thereof
US 12649771 B2
申请人: MEDYTOX INC
优先权: 2020
EP
US
WO
5 件公开
Treatment of kidney disorders with VIP fragments
US 8569235 B2
申请人: DUGGAN KAREN ANNETTE
优先权: 2008
CN
US
5 件公开
COMPOSITIONS AND METHODS FOR ANTI-PACAP IGG4 ANTIBODIES
EP 4658683 A1
申请人: CEPHALON LLC
优先权: 2023
CN
EP
US
WO
4 件公开
Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
US 2008221041 A1
申请人: BLOCK LUTZ-HENNING
优先权: 2000
CN
US
4 件公开
Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
US 2006241028 A1
申请人: BEVEC DORIAN
优先权: 2002
CN
US
4 件公开
Methods for the treatment of aortic fibrosis with VIP fragments
US 8729020 B2
申请人: DUGGAN KAREN ANNETTE
优先权: 2009
CN
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈